Table 2.

Efficacy Data by Arm

Arm	PFS6	ORR (measurable only)	mPFS	mOS	mPFS (non-BRCA or PALB2)	mOS (non-BRCA or PALB2)	mPFS (no DDR variant)	mOS (no DDR variant)
	% (95% CI)		Mo (95% CI)
Nira/Nivo	N = 44	N = 42	N = 44	N = 44	N = 37	N = 37	N = 32	N = 32
Nira/Ipi	N = 40	N = 39	N = 40	N = 40	N = 33	N = 33	N = 30	N = 30
Nira/Nivo	20.6 (8.3-32.9) p=0.0002 vs 44%	7.1 (1.5-19.5)	1.9 (1.4-2.3)	13.2 (8.1-16.7)	1.9 (1.8-1.9)	13.2 (8.1-16.7)	1.8 (1.8-1.9)	13.2 (6.1-20.3)
Nira/Ipi	59.6 (44.3-74.9) p=0.045 vs 44%	15.4 (5.9-30.5)	8.1 (5.5-10.6)	17.3 (12.8-21.9)	7.6 (4.0-11.1)	17.3 (12.5-22.2)	7.6 (2.8-12.3)	15.0 (4.3-25.7)

Italics indicate lack of overlap between CIs